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ABSTRACT
Successful gene therapy depends on the develop-
ment of efficient, non-toxic gene delivery systems.
To accomplish this objective, our laboratory has
focused on solid-phase synthesized peptide carriers,
in which the amino acid sequence can be varied pre-
cisely to augment intracellular DNA transport. We
previously determined that linear and branched co-
polymers of histidine and lysine in combination with
liposomes enhanced the efficiency of gene transfec-
tion. In this study, we have modified two branched
histidine-lysine (HK) peptides by adding a histidine-
richtail.Inavariety ofcelllines,this histidine-richtail
markedly improved transfection efficiency, presum-
ably by increasing the buffering capacity of the poly-
mer. One polymer with a histidine-rich tail, H
2K4bT,
compared favorably with the commonly used trans-
fection agents. Together with modification of our
transfection protocol, these improved HK peptides
alone, without liposomes, are the effective carriers
of plasmids into a variety of cells. We anticipate that
branched HK peptides will continue to be developed
as carriers of nucleic acids for in vitro and in vivo
applications.
INTRODUCTION
Non-viral carriers offer the potential of delivering genes to
targets in a highly efﬁcient, safe and speciﬁc manner. Among
the non-viral candidates for gene delivery, which include lipo-
somes, peptides, proteins and synthetic non-peptide polymers
(1–6), our laboratory has focused primarily on solid-phase
synthesized peptides that mediate gene transfer. These trans-
fection peptides have not gained widespread use as sole car-
riers of nucleic acids nor have they been commercially viable,
partly because of their low-transfection efﬁciency compared
with that of other non-viral methods. Nevertheless, there have
been a few promising examples using these peptides as
transfection carriers, including (LARL6)-a-helical, MPG
and KALA peptides (7–9). In contrast to these infrequently
used peptide carriers, the related dendrimeric polymers [poly-
ethylinimine (10,11), SuperFect (3) and polyamidoamine
(12,13)] have been more commonly used and in general
have higher transfection efﬁciency. Peptides synthesized by
solid-phase offer potential advantages, however, in that the
amino acid sequence can be varied considerably to augment
transfection yet the amino acid sequence can be carefully
controlled within the peptide.
We previously demonstrated that branched peptides, when
combined with cationic liposomes, were efﬁcient carriers of
plasmids (14,15). The branched co-peptide is comprised of
lysine and histidine; the lysine component forms a complex
with and partially neutralizes the negative charge of the plas-
mid DNA, and the histidine component with a pKa of 6.0,
buffers and aids in the release of plasmid DNA from endo-
somal vesicles. Without liposomes, however, the branched
histidine–lysine (HK) peptides were not efﬁcient carriers of
nucleic acids in many cell lines.
Our goals in this study were 2-fold. First, we wanted to
identify a branched polymer that was a more effective
in vitro carrier of DNA into cells without the aid of liposomes.
Webelievethatsuchasolepeptide carrier hasintrinsicadvant-
ages over the more complicated bipartite carrier. To accom-
plish this, we designed several peptides that were enriched
with histidines. Although HK peptides already have histidines
within their structure, we reasoned that further increases in
histidine content within the polymer would increase transfec-
tion. Nevertheless as we determined, the location of this
histidine-rich domain within the peptide was critical for
enhancing transfection.
In addition to discovering better peptide carriers, we
developed a simpliﬁed protocol, which took advantage of
some of the properties of HK peptides. As such peptides in
complex with DNA are stable to the effects of serum, we
thought that this might permit prolonged exposure of the intact
complex with the cells and thereby increase transfection. In
this study, we report a simple and effective protocol that
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MATERIALS AND METHODS
Cell culture and media
MDA-MB-435, MDA-MB-231 and MCF7 (three human
cancer cell lines), as well as SVR-bag4 (SV-40-transformed
endothelial cells) were maintained in the DMEM containing
10% fetal calf serum (FCS) and 20 mM glutamine at 37Ci n
an atmosphere of 95% humidiﬁed air and 5% CO2.
HK peptides
The biopolymer core facility at the University of Maryland
synthesized the peptides on a Ranin Voyager synthesizer (PTI,
Tucson, AZ) as described previously (16). The following pep-
tides (Figure 1 and Table 2) were synthesized: (i) H
3K4b, (ii)
H
3K4bT, (iii) H
2K4b, (iv) H
2K4bT, (v) H
2K4bNLS1, (vi)
H
2K4bNLS2 and (vii) H
2K4bRGD. H
3K4b and H
3K4bT
were similar except that the latter has a histidine-rich tail;
similarly, H
2K4b and H
2K4bT have the same structure except
that H
2K4bT has a histidine-rich tail. Polymers (v)–(vii) were
similar in structure to H
2K4bT except that the histidine-rich
tail has been replaced with other transfection augmenting
groups (Table 2). The peptides were puriﬁed on a high-
performance liquid chromatography (Beckman, Fullerton,
CA) and analyzed using mass spectroscopy (Perseptive
Biosystems, Foster City, CA) to verify the predicted molecular
mass.
Titration of HK peptides
Titrations of HK peptides were performed as described
previously for dextran-grafted polyethylenimine (17) with
minor modiﬁcations. In brief, HK peptides were diluted to
a concentration of 0.1 N NaCl and the pH was adjusted to
4.5 before titration. An aliquot of 10 ml (10
3 mEq) of 0.1 N
NaOH wassequentiallyaddedto12mlofa0.1mg/mlpolymer
solution, and pH changes were recorded.
Preparation of liposomes
Preparation of the liposome–plasmid complexes have been
described previously(18).Inbrief, DH5a bacteria (Invitrogen,
Figure1. SchematicstructureofbranchedHKpeptides.H
3K4bandH
3K4bT:thesepeptideshaveasimilarDNA-bindingdomain(R),butH
3K4bandH
3K4bTdiffer
in that H
3K4bT has a histidine-rich tail. H
2K4b and H
2K4bT: similarly, the difference between H
2K4b and H
2K4bT is that the latter has a histidine-rich tail.
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Superbroth to mid-log phase. The plasmids, PCI-Luc or
PCI-bgal, were then puriﬁed with Qiagen columns (Valencia,
CA). An analytical gel of each plasmid (cut and uncut) was
performed to ensure that there was no contamination with
other nucleic acids. Liposomes were comprised of 1,2-
dioleoyl-3-trimethylammonium-propane (DOTAP) (Avanti,
Birmingham, AL). After hydration of the lipids, the liposomes
were sonicated until clear with a Branson 1210 bath sonicator
in the presence of argon. The liposomes were then extruded
through 50 nm polycarbonate membranes with LipsoFast-
Basic (Avestin Inc., Ottawa, ON). The ﬁnal concentration
of the liposomes was 1 mg/ml.
Transfection protocol
Initially, 1 · 10
5 cells were plated in 24-well plates in the
presence of 500 ml of DMEM with 10% serum; after 24 h, the
cells reached 70% conﬂuency. Unless otherwise indicated,
4 mg of the polymer (in 8 ml) were mixed with 1.0 mg of the
plasmid (PCI-Luc or PCI-bgal in 42 ml of Opti-MEM) and the
mixture was allowed to stand for 30 min. Similarly, DOTAP
(4 mg), Lipofectamine (2, 4 or 8 mg) (Invitrogen) and Super-
Fect(5mg)(Qiagen)were mixedwith1mgofPCI-Luc,andthe
mixture was allowed to stand for 30 min. To prepare the
combinationcarrier,the HKco-polymer (4mg)was ﬁrst incub-
ated with PCI-Luc (1.0 mg) for 30 min in Opti-MEM, and then
cationic liposomes (1, 1.5 or 2 mg) were then added, gently
mixed and allowed to stand for an additional 30 min. The
standard or one-step protocol was then performed.
The standard protocol was performed as described
previously with a few modiﬁcations (14). In brief, 50 mlo f
the transfection complex were mixed with 200 mlo f
Opti-MEM and this was then added to the cells for 4 h.
The cells were washed once with phosphate-buffered saline
(PBS), DMEM + 10% serum was then added and incubation
was continued for a further 24 h. The reporter assay was then
performed.
With the one-step method, the transfection complex (50 ml
of the carrier–DNA complex) was added tothe well containing
the cells and 500 ml of DMEM containing 10% serum. After
24 h, the appropriate reporter assay was then performed.
Luciferase reporter assay
After the cellswere washed once with 1·PBS,they were lysed
with 100 mlo f1 · passive lysis buffer (Promega Corp.,
Madison, WI). Protein concentration was measured by
using the BCA protein assay kit (Pierce). Luciferase activity
was measured by the direct current Turner 20/20 luminometer
(Turner Design, Sunnyvale, CA) as described previously
(14,19), and relative light units were converted into picograms
(pg) of luciferase by using recombinant luciferase (Promega)
as a standard. Duplicate measurements were performed for
each concentration and three separate experiments were con-
ducted; the data from the luciferase activity was expressed as
the mean – SEM.
b-Galactosidase staining
MDA-MB-435 cells, at 60% conﬂuency, were stained with
the b-galactosidase staining kit in accordance with the man-
ufacturer’s instructions (Invitrogen). In brief, the growth
medium was removed from the transfected cells (transfected
by PCI-Luc) and the cells were rinsed once with PBS. The
cells were ﬁxed for 10 min at room temperature, rinsed twice
with 1· PBS, and then X-Gal staining solution was added to
the cells for6 hat 37C. At least200 cells were counted in four
different ﬁelds (200·) and those cells that stained blue were
counted as expressing b-galactosidase; in MDA-MB-435 cells
transfected with a control plasmid (PCI-Luc), no background
staining was observed.
Flow cytometry
To determine cellular toxicity after transfection with the
peptide and DNA complexes, we followed the manufacturer’s
instructions for the Vybrant Apoptosis Assay #4 (Molecular
Probes). Twenty-four hours before transfection, 2 · 10
5 MDA-
MB-435 cells were plated in each well of 12-well plates.
The cells were transfected with a luciferase-expressing plas-
mid (2 mg) in complex with the carrier (peptides H
3K4bT or
H
2K4bT; 8 mg). The cells were then harvested after 24 h,
washed in ice-cold 1· PBS, and the cells were suspended
in 1 ml of PBS. To this suspension, 1 ml of the green ﬂuor-
escent dye stock solution (YO-PRO-1) and 1 ml of the red
ﬂuorescent stock solution (propidium iodide) were added.
After incubation on ice for 30 min, the number of cells
that were necrotic and/or apoptotic was analyzed by the
FACScan using 488 nm excitation (Becton Dickinson, San
Jose, CA).
Measurement of particle size of peptide–DNA complexes
The branched peptide (4 mgi n8ml of Opti-MEM) was mixed
with the plasmid (PCI-Luc, 1 mgi n4 2ml of Opti-MEM); after
standing for 30 min at room temperature, another 450 mlo f
Opti-MEM was added to the complex. The peptide–DNA
complex particles were then measured using a N4 Submicron
Particle Sizer (Coulter, Miami, FL).
RESULTS AND DISCUSSION
Comparison of the 4 and 24 h transfection efficiency in
MDA-MB-435 cell line
In the previous studies, after preparing the transfection
complex, we incubated the carrier–DNA complex with the
cells in the absence of serum for 4 h, after which we washed
the cells, added growth medium with 10% serum, and meas-
ured reporter activity 24 h later. We wanted to compare this
method with the one-step method in which the transfection
complex was added directly to the well containing the cells
and growth medium with 10% serum. After 24 h, we measured
the luciferase activity. To compare these two transfection pro-
tocols, we used four carriers: DOTAP liposomes, Lipofectam-
ine, H
3K4b and H
2K4b. Compared with the one-step method,
the DOTAP and Lipofectamine carriers were considered to be
the more effective carriers in the standardtransfection method.
H
2K4b was the best carrier of the luciferase-containing
reporter plasmid for both the standard and the one-step
method; however, the one-step method using the H
2K4b
carrier was 7-fold more effective than the standard method
(Figure 2). In addition to simplifying the transfection
protocol, results from this one-step method indicate that
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2K4b polymer in complex with plasmid DNA was stable
in DMEM containing 10% serum for prolonged periods
of time.
HK peptides with a histidine-rich tail enhance gene
transfection efficiency in the MDA-MB-435 cell line
Although branched peptides are effective carriers of
luciferase-containing plasmids with the modiﬁed protocol,
we reasoned that these peptides could be improved by
increasing their buffering capacity. Peptides with buffering
capacity augment transfection by inducing endosomal
swelling and lysis. Nevertheless, the location where the
histidine-rich domain was added to the polymer was critical.
For example, when the histidine-rich domain was moved to
each of the four DNA-binding arms of the HK branched poly-
mer (Figure 1), transfection efﬁciency decreased signiﬁcantly
(data not shown). As a result, we added the histidine-rich
domain to a region of the HK peptides, which did not affect
its ability to bind DNA (Figure 1). The addition of the
histidine-rich domain increased the buffering capacity of
the HK polymers, which is evident from the greater resistance
to pH changes (Figure 3; H
3K4b versus H
3K4bT and H
2K4b
versus H
2K4bT). We then tested if addition of a histidine-rich
domain to the carrier affected transfection activity. The dif-
ference in luciferase activity of transfected cells between
H
3K4bT (with a histidine-rich domain) and H
3K4b (without
a histidine-rich domain) was >100-fold; the average luciferase
activity for the H
3K4b and H
3K4bT carriers of PCI-Luc was
2.7 and 420 pg/mg-protein, respectively (Figure 4). Although
the magnitude of the difference between H
2K4b and H
2K4bT
was not as great (1.8-fold) as in MDA-MB-435 cell line
(Figure 4), H
2K4bT was the most effective branched HK car-
rier in transporting plasmids in this and all other tested cell
lines. Notably, the size of these complexes could not explain
the transfection differences mediated by these four HK
peptides (Table 1).
Comparison of lacZ transfection efficiency in
MDA-MB-435 with the four different HK polymers
We then determined the transfection efﬁciency of the HK
peptides as carriers, by transfecting the plasmid lacZ with
different peptide carriers into the MDA-MB-435 cell line
and then staining for b-galactosidase activity within the
cells (Figure 5). In general, the results obtained by staining
the cells with b-galactosidase correlated closely with the luci-
ferase activity results. H
2K4bT had the highest transfection
efﬁciency followed by H
2K4b. The one interesting exception
Figure 2. Comparison of 4 and 24 h transfection efficiency in MDA-MB-435
cells. MDA-MB-435 cells were transfected with DOTAP (2:1), Lipofectamine
(4:1), H
3K4b (4:1) and H
2K4b (4:1) in complex with the PCI-Luc. For the 4 h
transfection, the complex was incubated in Opti-MEM without serum for 4 h,
the cells were washed, and DMEMcontaining 10% FCS was added; after 24 h,
luciferase activity was measured. For the 24 h transfection experiments, the
complex was added directly to the wells containing the 10% FCS DMEM and
cells; after 24 h, luciferaseactivity wasmeasured as described in Materialsand
Methods. *, P < 0.001; H
2K4b (24 h) versus H
2K4b (4 h); DOTAP (4 h) versus
DOTAP (24 h); Lipofectamine (4 h) versus Lipofectamine (24 h); t-test.
Figure 3. Titration of HK peptides. After the pH of the HK peptide solutions (0.1 mg/ml polymer solution in 0.1 N NaCl) was adjusted to 4.5, 10 ml (10
3 mEq)
aliquotsof0.1NNaOHwasthensequentiallyaddedto12ml,andpHchangeswererecorded.Thedatarepresentthemeanofduplicateexperiments.(A)H
3K4band
H
3K4bT; and (B)H
2K4b and H
2K4bT. Open circles represent HK peptides with a histidine-rich tail.
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3K4bT. Luciferase activity after transfection with
H
3K4bT and H
2K4b were similar in MDA-MB-435 cells,
but H
3K4bT had more than a 2-fold reduction in b-galactosi-
dase staining compared with H
2K4b. One explanation for this
is that the histidine-rich tail may augment lysing the endo-
somal compartment, which is known to increase transfection.
Although fewer cells were transfected with the histidine-rich
tail polymer, H
3K4bT, compared with H
2K4b, the histidine-
rich polymer apparently is more potent at augmenting the
degree of transfection per cell. Notably also, the transfection
efﬁciency differs between H
3K4b, where there is a lysine for
every three histidines, and H
2K4b, where the lysines are sep-
arated on average by 1.8 histidines; the lower transfection
efﬁciency by H3K4b is probably due to the reduced ability
of the polymer to bind DNA.
The H
2K4bT transfection agent without liposomes was
more effective
We wanted to identify a branched polymer that was an
effective carrier of plasmid DNA into cells without the aid
of liposomes. We thus compared the most effective HK poly-
mer, H
2K4bT, with and without liposomes for their ability to
transfect MDA-MB-435 cells. H
2K4bT was more effective as
a sole carrier of a luciferase expressing plasmids compared
with when it was combined with liposomes (Figure 6). Sim-
ilarly, H
2K4bT alone was more effective as a carrier compared
with the liposome and polymer combination in other cell lines
tested (MDA-MB-231, MCF-7 and SVR-bag4) (data not
shown).
Comparison of transfection with modified branched
peptides in several cell lines
We then compared the ability of these HK peptides in
transfecting three additional different cell lines (MDA-MB-
231, MCF-7 and SVR-bag4). In these three cell lines, H
2K4bT
was the optimal polymer for transfecting PCI-Luc. Compared
with its parent polymer (H
2K4b), H
2K4bT had an 8-fold
higher transfection in MDA-MB-231 cells, a 1.4-fold higher
transfection in MCF-7 cells and a 2-fold higher transfection in
SVR-bag4 cells (Figure 7).
Comparison of transfection ability of H
2K4bT with
other transfection agents in four cell lines
We compared the transfection efﬁciency of H
2K4bT with two
commonly used transfection reagents, Lipofectamine and
SuperFect, in four cell lines (Figure 8). In the cell lines,
H
2K4bT was clearly most effective than Lipofectamine
with the one-step protocol; the polymer was at least 4-fold
most effective than Lipofectamine. In comparison with Super-
Fect, H
2K4bT was most effective as a transfection agent in
three of the four cell lines. When the one-step protocol
using H
2K4bT was compared with the standard method
using Lipofectamine, the polymer was signiﬁcantly better
as a transfection agent in three of the four cell lines (data
not shown). Although H
2K4bT compared favorably with
these transfection agents under the conditions employed,
our primary goal remains the continued improvement of the
HK polymer as a transfection agent.
The histidine-rich side chain is most effective
To determine whether other side groups might be more
effective than the histidine-rich tail, we examined the effect
of side groups, which, as part of transport mechanisms, have
been reported to augment transfection (Table 2) (2,20–22). We
selected two nuclear localization signals (see peptides
H
2K4bNLS1 and H
2K4bNLS2 in Table 2) to aid transport
of the polymer and presumably its DNA cargo into the nuc-
leus, and an integrin-speciﬁc ligand (see H
2K4bRGD peptide),
which augments the initial attachment and internalization of
the complex in MDA-MB-435 cells that express av integrins
(23). However, these modiﬁcations were signiﬁcantly less
effective than the histidine-rich tail suggesting that endosomal
lysis is a critical step in achieving high transfection.
Minimal toxicity observed with HK polymers with a
histidine-rich tail
After staining the transfected MDA-MB-435 cell population
with the YO-PRO-1 and PI dyes, apoptotic cells showed green
ﬂuorescence, dead cells showed red and green ﬂuorescence,
and the viable cells showed little or no ﬂuorescence. Peptides
H
3K4bT and H
2K4bT as transfection carriers of plasmid
DNA (PCI-Luc) showed minimal toxicity compared with
the untreated cells (Figure 9). In duplicate transfection
Figure 4. Modified branched peptide with a histidine-rich tail enhances gene
transfectioninMDA-MB-435cells.MDA-MB-435cellsweretransfectedwith
PCI-Lucin complexwithoneofthefourHKbranchedpeptides:(i)H
3K4b,(ii)
H
3K4bT, (iii) H
2K4b and (iv) H
2K4bT. In transfecting these cells, the peptides
with a histidine-richtail (H
3K4bT and H
2K4bT) were more effective thantheir
counterparts without the tail. *, P < 0.001; H
3K4bT versus H
3K4b; H
2K4bT
versus H
2K4b; t-test.
Table 1. The polyplexes were prepared by mixing PCI-Luc plasmids (2 mg)
with the above polymers (8 mg) in Opti-MEM for 30 min
Polymer Polyplex size (nm)
H
3K4b 490.3 – 180.5
H
3K4bt 654.3 – 204.2
H
2K4b 869.9 – 341.1
H
2K4bT 760.9 – 92.4
The polyplexes were then diluted in Opti-MEM and the size of polyplexes was
measured on N4 plus Submicron Particle Sizer.
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(V), apoptotic (A) and necrotic (N) groups. For untreated cells,
the proportion of viable, apoptotic and necrotic cells was 96.6,
0.33 and 3.04, respectively; for H
3K4bT-transfected cells, the
proportion was 95.4 (V), 0.27 (A) and 4.33 (N); and for
H
2K4bT-transfected cells, the proportion was 96.0 (V),
0.27 (A) and 3.6 (N) (Figure 9). Similarly, a second cytotoxic
assay based on the release of lactate dehydrogenase from cells
conﬁrmed that the polymers, H
3K4bT and H
2K4bT, had min-
imal toxicity following transfection of MDA-MB-435 and
MDA-MB-231 (data not shown).
In this study, we describe development of an in vitro agent
that compares favorably with commonly used transfection
agents. Previously, we found that branched HK peptides as
sole DNA carriers were approximately one-third as effective
as cationic liposomes in many cell lines. With the change of
protocol and the addition of the histidine-rich tail to the
branched HK peptides, these peptides are as efﬁcient as
many commercial cationic carriers with respect to transfec-
tion. There are two explanations for the success of these pep-
tides as carriers of plasmid with the one-step protocol. First,
with the addition of the histidine-rich domain, these peptides
enhance the escape of DNA from the endosomal pathway to
a greater degree thereby avoiding the degradation of DNA by
lysosomes. Similar to other pH-sensitive functional groups,
the histidine-rich domain, by virtue of its buffering the acidic
Figure 5. Transfection efficiency of HK branched peptides. Twenty-fourhours after plating, MDA-MB-435 cells were transfected with 1 mg of the lacZ plasmid in
complex with one of following carriers: (A)H
3K4b (4:1), (B)H
3K4bT (4:1), (C)H
2K4b (4:1) and (D)H
2K4bT (4:1) [numbers in parentheses refer to the ratio of
carriertoDNA(w/w)].Onedayafterthecomplexeswereaddedtothecells,stainingforb-galactosidaseactivitywasperformedtodeterminetransfectionefficiency.
With the different carriers, the transfection efficiency with H
3K4b was 2%, with H
3K4bT was 19.2%, with H
2K4b was 36.4% and with H
2K4bT was 61.3%.
Figure 6. Evaluation of H
2K4bT co-polymer alone or in combination with
liposomes in their effects on transfection. The co-polymer (4 mg) was mixed
withDNA(1mgofPCI-Luc)andinsometreatmentgroups,liposomes(1,1.5or
2 mg) were then added; the mixture was then added to DMEM and 10% serum
containing the MDA-MB-435 cells. Twenty-four hours after transfection, the
cells were lysed to measure luciferase activity. The data represent the
mean – SEM of luciferase of three experiments. *, P < 0.01; H
2K4bT versus
H
2K4bT and liposome treatment groups (one-way ANOVA with bonferroni-
multiple comparisons).
Table2.Comparisonofgenedeliverycarriersinwhichthehistidine-richtailof
H
2K4bT has been replaced
Carrier Groups % Transfection
H
2K4bT -HHHHNHHHHN 100
H
2K4bNLS1 -GNYNNQSSNFGPMKGGN 33
H
2K4bNLS2 -PKKKRKV 8
H
2K4bRGD -GRGD 25
All carriers have the same DNA-binding branches but they have different tails.
H
2K4bThadthehighesttransfectionofaluciferaseplasmidandotherpolymers
transfection abilities were based on H
2K4bT (expressed as % transfection of
H
2K4bT).
e40 Nucleic Acids Research, 2005, Vol. 33, No. 4 PAGE 6 OF 9Figure 7. Ability of the branched HK peptides to transfect various cell lines. After plating the cells, PCI-Luc in complex with the carrier (H
3K4bT, H
2K4b and
H
2K4bT) transfected the different cell lines [MDA-MB-231 (A), MCF-7 (B) and SVR-bag4 (C)] as described in Material and Methods. *, P < 0.05; **, P < 0.01;
H
2K4bT versus H
2K4b and H
3K4bT (one-way ANOVA with bonferroni-multiple comparisons).
Figure 8. Comparison of H
2K4bT transfection efficiency with other transfection agents in different cell lines. The ability of H
2K4bT as a carrier of PCI-Luc was
comparedwithtwocommonlyusedtransfectioncarriers(LipofectamineandSuperFect)withtheone-stepmethodindifferentcelllines.Thefollowingfourcelllines
weretransfected:MDA-MB-435(A),MCF-7(B),MDA-MB-231(C)andSVR-bag4(D)(fordetailsoftransfectionseeMaterialsandMethods).*,P<0.05;H
2K4bT
versus SuperFect; **, P < 0.001; H
2K4bT versus Lipofectamine.
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of this protocol may be due to the ability of HK peptides to
form relatively stable interactions with DNA inthe presence of
serum, unlike many transfection carriers. When HK peptides
are compared with polylysine, the HK peptides in complex
with DNA are relatively inert to the destabilizing effects of
serum (16); we hypothesize that non-ionic interactions are
occurring between the histidine component of the peptide
and the DNA. This tolerance to serum allows longer exposure
of the complex to the cells with reduced toxicity.
Our long-term objectives were to develop effective carriers
for in vitro and in vivo applications. Preliminary data suggest
that these HK peptides can be efﬁcient carriers to the lungs and
to extrapulmonary tumors. The advantages of peptide-based
therapy are that the amino acid building blocks can be easily
manipulated to develop improved carriers and the speciﬁc
patterns of these peptides are inﬁnite. Currently, these peptides
are expensivetosynthesizeandhence the future challenge isto
lower the cost of their synthesis. We believe this can be per-
formed, at least in part, through assembling the different parts
of the branched polymer together rather than the current
en bloc synthesis that we now use.
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